Related references
Note: Only part of the references are listed.Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia
Tamam Bakchoul et al.
TRANSFUSION (2011)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Complement activation in vitro by antiplatelet antibodies in chronic immune thrombocytopenic purpura
T. Tsubakio et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura
Ellinor I. B. Peerschke et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Warm Autoimmune Hemolytic Anemia: Recent Progress in Understanding the Immunobiology and the Treatment
Melca M. O. Barros et al.
TRANSFUSION MEDICINE REVIEWS (2010)
The ITP syndrome: pathogenic and clinical diversity
Douglas B. Cines et al.
BLOOD (2009)
Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia
T. Bakchoul et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Expression of complement components and inhibitors on platelet microparticles
Wei Yin et al.
PLATELETS (2008)
Rapid detection of HPA-1 alloantibodies by platelet antigens immobilized onto microbeads
Tamam Bakchoul et al.
TRANSFUSION (2007)
Blood platelets activate the classical pathway of human complement
E. I. B. Peerschke et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Platelet activation leads to activation and propagation of the complement system
I del Conde et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura
B Olsson et al.
NATURE MEDICINE (2003)
The pathogenesis of chronic immune (idiopathic) thrombocytopenic purpura
R McMillan
SEMINARS IN HEMATOLOGY (2000)
Share Paper
